Skip to main content
Clinical Trials/ISRCTN68138140
ISRCTN68138140
Completed
未知

Molecular Diagnosis of Central Venous Catheter (CVC) associated infections

Department of Health (UK)0 sites330 target enrollmentDecember 14, 2004

Overview

Phase
未知
Intervention
Not specified
Conditions
Central Venous Catheter Associated Infections
Sponsor
Department of Health (UK)
Enrollment
330
Status
Completed
Last Updated
3 years ago

Overview

Brief Summary

2011 Results article in http://www.ncbi.nlm.nih.gov/pubmed/21294989 results

Registry
who.int
Start Date
December 14, 2004
End Date
September 30, 2009
Last Updated
3 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Department of Health (UK)

Eligibility Criteria

Inclusion Criteria

  • 1\. Child, adolescent or young adult aged zero 18 years inclusive
  • 2\. Undergoing treatment for cancer/leukaemia or severe haematological disorders at a collaborating United Kingdom Children's Cancer Study Group (UKCCSG) centre
  • 3\. The routine standard of care requires a tunnelled single, double or triple lumen CVC or implanted vascular port
  • 4\. It is expected that the CVC or port will be required for a minimum of three months
  • 5\. Patients who already have an indwelling vascular access device in situ at the time of recruitment are eligible if they have been apyrexial and have not received intravenous antimicrobial therapy in the preceding two weeks
  • 6\. Written informed consent has been obtained from the parent/guardian and assent from the patient where appropriate
  • 7\. National/Local Ethical Committee approval has been obtained

Exclusion Criteria

  • 1\. Failure to meet the above criteria
  • 2\. Patients with untunnelled CVCs or short term CVCs will not be included

Outcomes

Primary Outcomes

Not specified

Similar Trials